MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PF-06869206

CAS No. : 2227425-05-8

MCE 站：PF-06869206

产品活性：PF-06869206 是一种有效的，具有口服活性的选择性磷酸钠协同转运蛋白 NaPi2a (SLC34A1) 抑制剂，IC₅₀ 为 380 nM。

研究领域：Membrane Transporter/Ion Channel

作用靶点：Sodium Channel

In Vitro: PF-06869206 shows a balance of attributes with 380 nM NaPi2a inhibition potency, excellent subtype selectivity, and acceptable aqueous solubility (46 μM). PF-06869206 is profiled for potency in the rodent NaPi2a and NaPi2c cell lines. PF-06869206 shows comparable submicromolar activity for the human, rat, and mouse NaPi2a isoforms with IC₅₀s of 0.4±0.047 μM and 0.54±0.099 μM for rat NaPi2a and mouse NaPi2a, respectively.

In Vivo: PF-06869206 is evaluated in rodent PK studies to determine suitability for in vivo pharmacology exploration. Results show moderate clearance in both rat and mouse. Oral bioavailability at 5 mg/kg is good in rat and moderate in mouse. At higher oral doses of 50 mg/kg, supraproportional increases in exposure are observed in both species, suggestive of saturation of clearance. PF-06869206 has moderate terminal elimination half-life (t_1/2=1.35 h, and 0.75 h for Wistar-Han rats (10 mg/kg, iv), and C57BL6 mice (1 mg/kg, iv)). Furthermore, permeability is good (14×10^-6 cm/s), and rat liver microsome (RLM) clearance is low (<14 μL/min/mg; HLM=39 μL/min/mg).

相关产品：Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Orally Active Compound Library  |  Neuroprotective Compound Library  |  EIPA  |  Amiloride hydrochloride  |  Monensin sodium salt  |  Carbamazepine  |  5-(N,N-Hexamethylene)-amiloride  |  Riluzole  |  20(S)-Ginsenoside Rg3  |  Lidocaine  |  Amitriptyline hydrochloride  |  Cariporide  |  Lamotrigine  |  Ranolazine dihydrochloride  |  Flecainide acetate  |  Phenytoin  |  Zonisamide  |  Veratridine  |  Oxcarbazepine  |  A-803467  |  Triamterene  |  Flunarizine dihydrochloride  |  Vinpocetine  |  QX-314 chloride  |  Dronedarone  |  Propafenone hydrochloride  |  Mexiletine hydrochloride  |  Topiramate

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。